Epilepsy Comprehensive Update and Board Review
Epilepsy Board Review: Sept 25-26, 2026
Comprehensive Update: Sept 26-27, 2026
Marriott West Loop | 1750 W Loop S | Houston, Texas 77027
The Epilepsy Board Review & Comprehensive Updates Course is a 3-day educational symposium designed to educate neurologists, APPs, neurology residents, and epilepsy fellows involved in the care of patients with epilepsy.
This year’s in-person course will take place from Friday, September 25 through Sunday, September 27, 2026. Friday and Saturday will feature an epilepsy board review tailored to neurology residents, epilepsy fellows, general neurologists, and APPs looking to refine their EEG reading skills and prepare for the 2026 ABPN Epilepsy Boards. Saturday and Sunday will focus on practical, cutting-edge topics for neurologists and epileptologists caring for patients with epilepsy. The course will expand attendees’ knowledge and understanding of epilepsy and demonstrate how to deliver high-quality, evidence-based care.
Some of the many exciting highlights include:
- Focused lectures on all aspects of epilepsy care, including pharmacologic therapies, diagnostic testing, and surgical therapies.
- Discussion of etiology and electroclinical syndromes in both adult and pediatric patients.
- A lecture and discussion around SUDEP.
- Expert-led lectures on novel anti-seizure medications and evolving pharmacologic strategies.
- Insights into genetics and precision medicine and their growing role in epilepsy care.
- Updates on advances in surgical epilepsy and neuromodulation techniques.
- Exploration of the integration of artificial intelligence into clinical practice.
For more information, email [email protected].
Learning Objectives
- Identify clinical features that support a diagnosis of epilepsy and specific epilepsy syndromes.
- Recognize normal, abnormal and epileptiform EEG patterns.
- Appropriately choose antiseizure medications for patients with epilepsy based on clinical history, comorbidities and epilepsy subtype.
- Identify appropriate diagnostic testing in persons with epilepsy including testing in drug resistant epilepsy patients.
Accreditation Statement/Credit Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Antidote Education Company and UTHealth Houston Neurosciences. Antidote is accredited by the ACCME to provide continuing medical education for physicians.
Antidote designates this live activity for a maximum of 16.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
McGovern Medical School at UTHealth Houston Faculty Speakers
- Abdulrahman Alwaki, MD, Associate Professor, Department of Neurology, McGovern Medical School at UTHealth Houston
- Jay Gavvala, MD, MSCI, Associate Professor, Department of Neurology, McGovern Medical School at UTHealth Houston
- Katherine Harris, MD, Assistant Professor, Department of Neurology, McGovern Medical School at UTHealth Houston
- Kent Alan Heck, MD, Professor, Director Neuropathology, Vice Chair, Department of Pathology and Laboratory Medicine, McGovern Medical School at UTHealth Houston
- Shirin Jamal-Omidi, MD, Assistant Professor, Department of Neurology, McGovern Medical School at UTHealth Houston
- Nuria Lacuey Lecumberri, MD, PhD, Assistant Professor, Department of Neurology, McGovern Medical School at UTHealth Houston
- Samden Lhatoo, MD, FRCP, Professor and John P. and Katherine G. McGovern Distinguished Chair and Executive Vice Chair, Director, Texas Comprehensive Epilepsy Program, Co-Director, Texas Institute of Restorative Neurotechnologies, Department of Neurology, McGovern Medical School at UTHealth Houston
- Yosefa A. Modiano, PhD, Assistant Professor, Vivian L. Smith Department of Neurosurgery, McGovern Medical School at UTHealth Houston
- Nitin Tandon, MD, FAANS, Professor, Vice President, Strategy and Development, Co-Director, Texas Comprehensive Epilepsy Program, Co-Director, Texas Institute for Restorative Neurotechnologies, Vivian L. Smith Department of Neurosurgery, McGovern Medical School at UTHealth Houston
- Shelley Varnado, MD, Assistant Professor, Child & Adolescent Neurology, McGovern Medical School at UTHealth Houston
Invited Faculty Speakers
- Barbara Dworetzky, MD, Chief of Epilepsy and EEG, Brigham and Women’s Hospital
- Roohi Katyal, MD, Co-Director, Adult Epilepsy, Assistant Professor, Department of Neurology, LSU Health Shreveport
- Dennis Lal, PhD, Professor, Assistant VP of Precision Health, Executive Scientist, Executive Director, Center for Innovation in Health Informatics & Professor of Research,
The University of Texas Arlington and Cook Children’s Health Care System. - Lu Lin, MD, PhD, Associate Professor Department of Neurology, Baylor College of Medicine
- Brandy Ma, MD, MPH, Neurologist and Epileptologist Assistant Professor, Clinical Neurology, Stanley H. Appel Department of Neurology, Houston Methodist and Weill Cornell Medical College
- Shilpa Reddy, MD, MMHC, Associate Program Director, Clinical Neurophysiology and Epilepsy Fellowships, Assistant Professor, Department of Pediatric Neurology, Vanderbilt University Medical Center
- Sarah Schmitt, MD, Associate Professor Department of Neurology, Medical University of South Carolina
- Stephan Schuele, MD, MPH, Chief of Epilepsy and Clinical Neurophysiology Professor, Department of Neurology, Northwestern University Feinberg School of Medicine
- Elaine Seto, MD, PhD, Medical Director, EEG, Texas Children’s Hospital Assistant Professor, Department of Pediatrics-Neurology, Baylor College of Medicine
Accommodations
Guests can stay at the Marriott West Loop by Galleria. Book your room for the UTHealth Houston Epilepsy Board Review
Book before Aug 3 to get the event group rate.
Parking Information
-
- Hourly rate: $7
- Self-parking daily rate ~$32
- Valet daily rate ~$44
Educational Program
Epilepsy Board Review – Day 1 (Friday 8AM-5:30PM)
Adult and Pediatric EEG
- Normal EEG and electrophysiologic principles
- Normal variants
- Interictal and ictal EEG patterns
- ICU EEG interpretation
- Neonatal EEG
- Pediatric EEG interpretation
Epilepsy Classification and Epilepsy Syndromes
- Seizure and epilepsy classification systems
- Semiological case-based learning
- Pediatric and neonatal epilepsy syndromes
- Adult epilepsy syndromes
- Organic and psychogenic non-epileptic events
Care of Persons with Epilepsy
- Genetics in clinical practice
- Gender considerations in epilepsy
- Comorbidities and long-term outcomes
- Neuropsychiatric aspects of epilepsy
- Board Review Style Questions
Epilepsy Board Review – Day 2 (Saturday 8AM-5:30PM)
Medical Management of Epilepsy
- Status epilepticus updates
- Dietary therapies
- Antiseizure medication principles
- Pediatric pharmacology considerations
- Drug interactions and systemic illness considerations
Surgical Evaluation and Management
- Drug-resistant epilepsy and surgical referral criteria
- Neuroimaging in epilepsy (MRI, PET, SPECT, fMRI, MEG)
- Intracranial EEG and cortical mapping
- Neuromodulation therapies
- Epilepsy surgery outcomes
- Neuropathology of epilepsy
- Board Review Style Questions
Updates in Epilepsy – Day 1 (Saturday 8AM-5:30PM)
Clinical Updates for Special Populations
- Gender-related issues in epilepsy
- Autoimmune epilepsies
- Functional (non-epileptic) seizures
- Transition of care from pediatric to adult neurology
- Dietary and non-pharmacologic therapies
Novel Therapies and Precision Medicine
- Emerging antiseizure medications and clinical trials
- Rational polytherapy strategies
- Genetics in epilepsy diagnosis and management
- Precision medicine and gene-targeted therapies
Updates in Epilepsy – Day 2 (Sunday 8AM-12:30PM)
Technological Advancements in Epilepsy
- Minimally invasive surgical approaches
- Advances in neuromodulation
- Artificial intelligence in EEG and clinical practice
- AI-driven decision support systems
- Wearable devices and ambulatory EEG monitoring
- Mobile epilepsy care models
For more information, email [email protected].